COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.

Medicine (Baltimore) · 2022 · PMC9333081 · PMID 35905215

Europe PMC DOI

hedged sentences

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

at the limits of significanceP = .061so close (0.05 < p ≤ 0.1)

Lymphopenia was more common in GBS-C+ ( P = .025), and persisted even when the neurologic onset had followed the resolution of the antecedent infection, while CRP was at the limits of significance ( P = .061).

also in 23 other papers

did not reach statistical significanceno p-value reported

Facial involvement was prevalent in the GBS-C+ group (5/10 patients, vs 2/10, but the difference did not reach statistical significance); other clinical features (dysautonomia, sensory signs and symptoms, consciousness disturbances) were also similar between the 2 groups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.